Estimates have shown that there were 77 million people diagnosed with diabetes in India in 2019. This is expected to rise to over 134 million by 2045.
In Short
- The artificial pancreas helps maintain healthy glucose levels
- The newly developed system could aid countries like India
- The study published in the journal Nature Medicine details the first trial
Researchers at Cambridge University have successfully conducted the trial of an artificial pancreas that can give new lease of life to people suffering from type-2 diabetes. Powered by an algorithm, it combines an off-the-shelf glucose monitor and insulin pump with an app.
The burden of diabetes is continuously on the rise across the world and India is no different. Estimates have shown that there were 77 million individuals diagnosed with diabetes in India in 2019. This is expected to rise to over 134 million by 2045. The newly developed system could aid countries like India in fighting the diabetic burden.
Researchers from the Wellcome-MRC Institute of Metabolic Science at the University of Cambridge have developed an artificial pancreas that helps maintain healthy glucose levels. The app known as CamAPS HX is run by an algorithm that predicts how much insulin is required to maintain glucose levels in the target range.